Diagnostics News and Research

RSS

Study confirms MammaPrint's capabilities in determining patients likely to benefit from chemotherapy

Today, at the 11th Annual Meeting of the American Society of Breast Surgeons, Agendia, a world leader in molecular cancer diagnostics, announced that Breast Cancer Research and Treatment has published an important study demonstrating the benefit of adjuvant chemotherapy for patients with a high-risk of breast cancer recurrence according to the MammaPrint test. The ASBS meeting takes places April 28 - May 2, 2010, at the Bellagio in Las Vegas, where you can meet the Agendia team at booth # 314.

30 Apr 2010

Gen-Probe reports total revenues of $135.4M for first-quarter 2010

Gen-Probe Incorporated today reported financial results for the first quarter of 2010, highlighted by $135.4 million of total revenues and earnings per share of $0.48 on both a non-GAAP and GAAP basis.

30 Apr 2010

SeraCare reports 18% increase in second-quarter fiscal 2010 revenues

SeraCare Life Sciences, Inc., a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today reported operational and financial results for its second quarter of fiscal year 2010, ended March 31, 2010.

30 Apr 2010

Clarient reports 14.8% increase in first quarter 2010 revenue

Clarient, Inc., a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the biopharmaceutical industry, today reported financial results for the first quarter ended March 31, 2010.

30 Apr 2010

IMD seeks FDA regulatory clearance for NADiA ProsVue prostate cancer prognostic test

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that its IRIS Molecular Diagnostics (IMD) subsidiary has submitted a 510(k) pre-market notification application to the U.S. Food and Drug Administration (FDA) requesting regulatory clearance for NADiA®ProsVue™, a prostate cancer prognostic test. The test is designed to help physicians identify patients at low risk of cancer recurrence post radical prostatectomy.

29 Apr 2010

Caliper Life Sciences' first-quarter 2010 GAAP revenues increase 1% to $28.7M

Caliper Life Sciences, Inc., today reported its first quarter 2010 results.

29 Apr 2010

BD second-quarter revenues up 7.0% to $1.845 billion

BD (Becton, Dickinson and Company) today reported quarterly revenues of $1.845 billion for the second fiscal quarter ended March 31, 2010, representing an increase of 7.0 percent from the prior-year period, or 6.6 percent on a foreign currency-neutral basis.

From BD (Becton, Dickinson and Company) 29 Apr 2010

RadNet reports financial guidance for fiscal year 2010

RadNet, Inc., a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today reported financial guidance for the fiscal year ending December 31, 2010.

29 Apr 2010

miacom diagnostics announces new tests for faster diagnosis of sepsis

"Conventional PCR tests (PCR is short for polymerase chain reaction, a highly sensitive method of detecting nucleic acids) require several hours to produce a result. lucesco Bacteremia IVD panels are not only much faster with a result after only 30 minutes, they are also much more cost-efficient.

29 Apr 2010

SurModics reports second-quarter GAAP revenue of $18.4 million, up 6% sequentially

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, today reported financial results for the second quarter ended March 31, 2010.

29 Apr 2010

Celera reports net loss of $12.5M for first-quarter 2010

Celera Corporation today reported net revenues of $31.4 million for the first quarter of 2010 that ended March 27, 2010, compared to $45.7 million in the prior year quarter. For the first quarter of 2010, Celera reported a net loss $12.5 million, or $0.15 per share, compared to a net loss of $1.4 million, or $0.02 per share, for the prior year quarter.

28 Apr 2010

Life Technologies first-quarter non-GAAP 2010 revenue increases 13% to $887 million

Life Technologies Corporation today announced results for its first quarter ending March 31, 2010. Non-GAAP revenue for the first quarter was $887 million, an increase of 13 percent over the $785 million reported for the first quarter of 2009. Excluding the impact of currency and completed acquisitions and divestitures, organic revenue for the quarter grew 10 percent over the same period in the previous year.

28 Apr 2010

AES CHEMUNEX to distribute SDIX's RapidChek food pathogen detection systems in Europe

Strategic Diagnostics Inc., now doing business as SDIX, a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology, diagnostic, and food safety applications, today announced it has signed a distribution agreement with AES CHEMUNEX.

27 Apr 2010

ExonHit to acquire RedPath for upfront payment of $12.5M in cash and $10M in stock

RedPath Integrated Pathology, Inc., a cancer molecular diagnostics company headquartered in Pittsburgh, PA, announced today that it has entered into a binding agreement to be acquired by ExonHit Therapeutics, S.A., a leading French diagnostics and therapeutics biotech company for an upfront payment of $12.5M in cash and $10M in stock, and starting in 2012, subsequent additional payment up to $9.5M dependent on the achievement of sales targets.

27 Apr 2010

Scientists develop rapid point-of-care diagnostic test to measure CD4 T-cells

Scientists at Australia's Burnet Institute have developed a rapid point-of-care diagnostic test for the measurement of CD4 T-cells, a marker of the immune system for people living with HIV and AIDS.

27 Apr 2010

Opinions: G8 summit; World Malaria Day; Family planning; Global Food Security Act

As G8 development leaders gather in Halifax, Nova Scotia, this week to discuss priorities for the upcoming summit, Josette Sheeran, executive director of the WFP, calls for world leaders to focus on the nutritional needs of mothers and children in developing countries in a Toronto Star opinion piece.

27 Apr 2010

News outlets examine World Malaria Day 2010

Ahead of Sunday's World Malaria Day, news outlets examined global efforts to combat the disease and the mood among advocates.

27 Apr 2010

MorphoSys AG reports Q1 results for 2010

MorphoSys AG (FSE: MOR; Prime Standard Segment; TecDAX) today announced its financial results for the three months ending March 31, 2010 according to International Financial Reporting Standards (IFRS).

27 Apr 2010

BG Medicine, Inverness Medical Innovations enter agreement for galectin-3 test for Triage Meter Pro

BG Medicine, Inc. announced today that it has entered into an agreement with Inverness Medical Innovations, Inc.—a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management—for the development and commercialization of a galectin-3 test for Inverness' Triage® Meter Pro®. Galectin-3 is a novel biomarker that may play a role in detecting the development and progression of heart failure.

26 Apr 2010

Thoratec to sell ITC division to Danaher

Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it has signed a definitive agreement to sell its International Technidyne Corporation (ITC) division to Danaher Corporation ( DHR).

From Danaher 26 Apr 2010

Diagnostics News and Research

Study confirms MammaPrint's capabilities in determining patients likely to benefit from chemotherapy

Gen-Probe reports total revenues of $135.4M for first-quarter 2010

SeraCare reports 18% increase in second-quarter fiscal 2010 revenues

Clarient reports 14.8% increase in first quarter 2010 revenue

IMD seeks FDA regulatory clearance for NADiA ProsVue prostate cancer prognostic test

Caliper Life Sciences' first-quarter 2010 GAAP revenues increase 1% to $28.7M

BD second-quarter revenues up 7.0% to $1.845 billion

RadNet reports financial guidance for fiscal year 2010

miacom diagnostics announces new tests for faster diagnosis of sepsis

SurModics reports second-quarter GAAP revenue of $18.4 million, up 6% sequentially

Celera reports net loss of $12.5M for first-quarter 2010

Life Technologies first-quarter non-GAAP 2010 revenue increases 13% to $887 million

AES CHEMUNEX to distribute SDIX's RapidChek food pathogen detection systems in Europe

ExonHit to acquire RedPath for upfront payment of $12.5M in cash and $10M in stock

Scientists develop rapid point-of-care diagnostic test to measure CD4 T-cells

Opinions: G8 summit; World Malaria Day; Family planning; Global Food Security Act

News outlets examine World Malaria Day 2010

MorphoSys AG reports Q1 results for 2010

BG Medicine, Inverness Medical Innovations enter agreement for galectin-3 test for Triage Meter Pro

Thoratec to sell ITC division to Danaher

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News